Across TCGA pan-cancer cohorts, SNRNP40 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated SNRNP40 data layer compared with 24 for mass-spec protein and 5 for mass-spec protein.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher SNRNP40 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SNRNP40 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.
COAD, UCEC, and CESC are the cancer types where SNRNP40 Mutation most reproducibly stratifies survival.